Strategic Partnership Profile

Strategic Partnership Profile - GCC Market Entry

International Medical Company (IMC)

Procurement-driven market entry partner for filtration manufacturers seeking direct regulatory, institutional, and commercial access across Saudi Arabia and the GCC.

Established1993
LocationJeddah, Saudi Arabia
Who We Are

Over 30 Years of Direct Market Access

International Medical Company (IMC) is a Saudi-based medical distribution company with over 30 years of direct market access to governmental and private healthcare sectors across Saudi Arabia and the GCC.

We operate as a procurement-driven partner, not just a distributor.

Market Access

Direct Reach Across the Decision Layer

IMC has direct access to the procurement environments that determine adoption, contract volume, and long-term category growth.

Ministry of Health (MOH) hospitals
Military & Armed Forces hospitals
National Guard Health Affairs (NGHA)
Private hospitals and laboratories
GCC centralized procurement via NUPCO
Market Opportunity

Scale That Justifies Immediate Entry

80M+blood samples annually in Saudi Arabia & GCC
100M+filtration units demand
USD 300M+estimated market size annually
Commercial Commitment

Volume, Growth, and Pricing Discipline

IMC is prepared to activate the category with measurable annual demand, disciplined pricing, and a defined growth floor.

1,000,000Blood Filters annually
1,000,000Urine Filters annually
10%Minimum annual growth
Target Pricing

Target Pricing

Blood Filter<= $1
Urine Filter<= $0.5
Services We Provide

IMC Will Fully Manage the Route to Market

In exchange for exclusivity, IMC will own the commercial, regulatory, and market-access execution model.

01

Regulatory & Market Authorization

  • Full product registration with Saudi Food & Drug Authority (SFDA)
  • Handling all regulatory documentation and compliance
  • Managing import approvals and customs clearance
02

Product Evaluation & Clinical Adoption

  • Distribution of free samples to major hospitals, reference laboratories, and government healthcare facilities
  • Coordination of clinical evaluations
  • Performance validation and feedback collection from end users
03

Government Tender Access

  • Full participation in centralized procurement via NUPCO
  • Product listing and tender code registration
  • Pricing strategy, tender submission management, and high-volume contract execution
04

Private Sector Expansion

  • Direct sales to private hospitals
  • Direct sales to diagnostic labs and medical centers
  • Rapid market penetration through existing client network
05

Sales & Marketing Execution

  • Dedicated medical sales team across Saudi Arabia
  • Market education for new technology and centrifuge replacement concept
  • On-site demonstrations, training, exhibitions, and conferences
06

GCC Market Expansion

  • Gradual expansion into UAE, Kuwait, Qatar, Bahrain, and Oman
  • Replication of the Saudi success model across GCC markets
07

Investment Commitment

  • Investment in product registration and market entry strategy
  • Sales team expansion and marketing campaigns
  • Clinical awareness building, tender participation, and execution
Product Visuals

Engineering Drawings & Specifications

The product platform must support disposable, scalable filtration workflows that can replace conventional centrifugation in routine testing environments, backed by clear technical documentation.

Medical Innovations

Blood & Urine Separation Filter R&D Projects

Prototype-ready disposable filtration concepts for centrifuge-free sample preparation, clinical evaluation, and future OEM manufacturing.

Shared Housing Platform

Housing material
Medical grade transparent polypropylene (PP)
External diameter
55 mm
Effective filtration diameter
40 mm
Effective filtration area
12.56 cm²
Total height
30 mm
Inlet / Outlet
ISO 594 Luer Lock connections
Manufacturing Concept

Both filters use a transparent medical-grade PP capsule inspired by Millipore-style disc filter architecture. Internal components may incorporate glass fiber, PES, PVDF, polypropylene mesh, or equivalent membrane materials depending on performance requirements and OEM manufacturing specifications.

Blood Plasma Separation Filter

A disposable medical filtration device designed to separate plasma directly from 4-5 mL whole blood samples without centrifugation.

Blood input volume
4-5 mL
Plasma recovery
500-600 µL
Processing time
<= 5 minutes
Operation
Centrifuge-free
  1. Capillary Distribution ChamberMedical grade PP

    Distributes blood evenly across radial capillary micro-channels to reduce localized pressure and improve filtration efficiency.

  2. Glass Fiber Prefilter Layer20-30 µm

    Removes aggregates, clots, and large particles before the separation membranes.

  3. WBC Separation Layer8-10 µm

    Retains white blood cells and larger cellular components.

  4. RBC Separation Layer3-5 µm

    Retains red blood cells while allowing plasma to continue through the filtration path.

  5. Plasma Separation Membrane~1 µm

    Provides final plasma clarification while preventing cellular carryover.

  6. Plasma Collection Mesh

    Collects and distributes filtered plasma uniformly to improve recovery efficiency.

  7. Drainage Layer

    Provides unobstructed plasma flow toward the outlet port.

Performance Target

  • 4-5 mL whole blood input
  • 500-600 µL plasma recovery
  • <= 5 minutes processing time
  • No centrifuge required

Urine Sediment Separation Filter

A disposable filtration device that separates urinary sediments from 4-5 mL urine samples while providing clear urine for strip testing.

Urine input volume
4-5 mL
Output
Clear urine for strip testing
Sediment use
Concentrated microscopy disc
Operation
No centrifuge required
  1. Distribution LayerMedical grade PP

    Ensures uniform urine distribution across the filtration surface.

  2. 20 µm Filter Layer

    Captures large particles, debris, casts, and mucus.

  3. 5 µm Filter Layer

    Retains larger urinary crystals and cellular components.

  4. 1 µm Filter Layer

    Concentrates finer sediments and microscopic particles.

  5. 0.45 µm Filter Layer

    Provides final clarification of the urine sample.

  6. Sediment Collection Disc

    Collects concentrated urinary sediments and can be removed for microscopic examination.

  7. Drainage Layer

    Allows efficient flow of clarified urine toward the outlet.

Sediment Collection Targets

Red Blood Cells (RBCs)White Blood Cells (WBCs)CrystalsCastsCellular debris

Performance Target

  • 4-5 mL urine input
  • Clear urine output for strip testing
  • Concentrated sediment for microscopy
  • Rapid sample processing
Mandatory

Exclusive Distribution Rights for Saudi Arabia & GCC Are Non-Negotiable

Exclusive distribution rights for Saudi Arabia & GCC are mandatory.

Reason

  • Protection from price undercutting in government tenders
  • Ensuring ROI on regulatory and market investment
  • Maintaining controlled pricing and brand positioning
Manufacturer Expectations

What We Expect from the Manufacturer

  • Finished filtration devices (not raw membranes)
  • Custom design capability (capsule / cartridge / syringe filters)
  • Stable supply and scalable production
  • Competitive pricing aligned with market requirements
Strategic Goal

Replace Conventional Centrifugation

To replace conventional centrifugation with disposable filtration systems that are faster, cost-effective, and operationally simpler.

FasterCost-effectiveDisposable filtration systems
Contact

Contact IMC

Manufacturers should leave this profile with a clear picture of the market, the execution plan, and the commercial seriousness behind the partnership proposal.

International Medical Company (IMC)

LocationJeddah, Saudi Arabia